This activity focuses on using busulfan to manage and treat allogeneic hematopoietic progenitor cell transplantation, particularly for patients with chronic myelogenous leukemia and other relevant disorders. As an antineoplastic alkylating agent, busulfan is a crucial medication for treating these conditions, which warrants a review of its indications, mechanisms of action, and contraindications. By exploring its pharmacokinetics, dosing regimens, adverse event profile, and clinical toxicology, this program equips participants with the knowledge to optimize busulfan therapy. This activity also discusses the significance of informed prescription practices and tailored dosage strategies to enhance treatment efficacy while minimizing potential adverse effects, thereby improving patient outcomes in managing chronic myelogenous leukemia and related conditions.Healthcare practitioners will gain an understanding of busulfan therapy, empowering them to deliver precise, secure, and individualized care to patients requiring allogeneic hematopoietic progenitor cell transplantation. By thoroughly examining FDA-approved and off-label uses, monitoring protocols, and pertinent drug interactions, participants will acquire the knowledge necessary to correctly administer busulfan, ultimately improving patient outcomes in treating chronic myelogenous leukemia and related disorders.
- Provider:StatPearls, LLC
- Activity Link: https://www.statpearls.com/ArticleLibrary/viewarticle/18732
- Start Date: 2023-09-01 05:00:00
- End Date: 2023-09-01 05:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 1.5 hours
Nursing: 1.5 hours
Pharmacy: 1.5 hours - MOC Credit Details: ABS - 1.5 Point; Credit Type(s): Accredited CME (ABS)
ABPATH - 1.5 Point; Credit Type(s): Lifelong Learning (ABPATH)
ABA - 1.5 Point; Credit Type(s): Lifelong Learning (ABA)
ABIM - 1.5 Point; Credit Type(s): Medical Knowledge (ABIM)
ABS - 1.5 Point; Credit Type(s): Self-Assessment (ABS)
ABP - 1.5 Point; Credit Type(s): Lifelong Learning and Self-Assessment (ABP) - Commercial Support: No
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: Variable
- Measured Outcome: Learner Knowledge, Learner/Team Competence
- Provider Ship: Directly Provided
- Registration: Open to all
- Specialty: Ambulatory/Outpatient, Chemical Pathology, Complex General Surgical Oncology, General Operative Anesthesia, General Pediatrics, General Surgery, Hematology, Hospital Medicine, Internal Medicine, Medical Oncology, Neonatal-Perinatal Medicine, Pediatric Hematology-Oncology